Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Recruiting · NCT07630649 · Registry updated 2026-08-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), eye disorder, macular degeneration, nervous system disorder, retinal degeneration, retinal disorder, vision disorder | Recruiting | Phase 2 | 2026-08-05 | NCT07630649 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Adverum Biotechnologies, Inc. | 6 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Adverum site 107 | The Woodlands | United States | 1 |
| Adverum site 109 | Bakersfield | United States | 1 |
| Adverum site 122 | West Columbia | United States | 1 |
| Adverum site 124 | Deerfield Beach | United States | 1 |
| Adverum site 126 | Phoenix | United States | 1 |
| Adverum site 149 | ‘Aiea | United States | 1 |
| Adverum site 168 | Jacksonville | United States | 1 |
| Adverum site 169 | Fullerton | United States | 1 |
| Adverum site 171 | Teaneck | United States | 1 |
| Adverum site 176 | Fort Lauderdale | United States | 1 |
| Adverum site 179 | Lemont | United States | 1 |
| Adverum site 231 | The Woodlands | United States | 1 |